These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
225 related articles for article (PubMed ID: 33599141)
21. Complementary Role of CMR to Conventional Screening in the Diagnosis and Prognosis of Cardiac Sarcoidosis. Kouranos V; Tzelepis GE; Rapti A; Mavrogeni S; Aggeli K; Douskou M; Prasad S; Koulouris N; Sfikakis P; Wells A; Gialafos E JACC Cardiovasc Imaging; 2017 Dec; 10(12):1437-1447. PubMed ID: 28330653 [TBL] [Abstract][Full Text] [Related]
22. Prevalence of cardiac sarcoidosis in patients presenting with monomorphic ventricular tachycardia. Nery PB; Mc Ardle BA; Redpath CJ; Leung E; Lemery R; Dekemp R; Yang J; Keren A; Beanlands RS; Birnie DH Pacing Clin Electrophysiol; 2014 Mar; 37(3):364-74. PubMed ID: 24102263 [TBL] [Abstract][Full Text] [Related]
23. Inpatient characteristics, complications, and outcomes of patients with cardiac sarcoidosis: A study from the National Inpatient Sample. Taduru SS; Goyal A; Dalia T; Mastoris I; Rali AS; Acharya P; Weidling R; Sauer A; Haglund N; Shah Z Indian Heart J; 2022; 74(2):148-150. PubMed ID: 35104459 [TBL] [Abstract][Full Text] [Related]
24. The ECG in sarcoidosis - a marker of cardiac involvement? Current evidence and clinical implications. Willy K; Dechering DG; Reinke F; Bögeholz N; Frommeyer G; Eckardt L J Cardiol; 2021 Feb; 77(2):154-159. PubMed ID: 32917454 [TBL] [Abstract][Full Text] [Related]
25. Long-term outcomes in young patients with atrioventricular block of unknown aetiology. Dideriksen JR; Christiansen MK; Johansen JB; Nielsen JC; Bundgaard H; Jensen HK Eur Heart J; 2021 Jun; 42(21):2060-2068. PubMed ID: 33599276 [TBL] [Abstract][Full Text] [Related]
26. Recovery of atrioventricular block following steroid therapy in patients with cardiac sarcoidosis. Yodogawa K; Seino Y; Shiomura R; Takahashi K; Tsuboi I; Uetake S; Hayashi H; Horie T; Iwasaki YK; Hayashi M; Miyauchi Y; Shimizu W J Cardiol; 2013 Nov; 62(5):320-5. PubMed ID: 24016620 [TBL] [Abstract][Full Text] [Related]
27. Right ventricular involvement and the extent of left ventricular enhancement with magnetic resonance predict adverse outcome in pulmonary sarcoidosis. Smedema JP; van Geuns RJ; Ector J; Heidbuchel H; Ainslie G; Crijns HJGM ESC Heart Fail; 2018 Feb; 5(1):157-171. PubMed ID: 28967698 [TBL] [Abstract][Full Text] [Related]
28. Clinical problem-solving. The beat goes on. Britton KA; Stevenson WG; Levy BD; Katz JT; Loscalzo J N Engl J Med; 2010 May; 362(18):1721-6. PubMed ID: 20445184 [No Abstract] [Full Text] [Related]
29. Cardiac sarcoidosis: the Christchurch experience. Adamson P; Melton I; O'Donnell J; MacDonald S; Crozier I Intern Med J; 2014 Jan; 44(1):70-6. PubMed ID: 24450522 [TBL] [Abstract][Full Text] [Related]
31. Electrocardiographic abnormalities and risk of developing cardiac events in extracardiac sarcoidosis. Nagao S; Watanabe H; Sobue Y; Kodama M; Tanaka J; Tanabe N; Suzuki E; Narita I; Watanabe E; Aizawa Y; Minamino T Int J Cardiol; 2015; 189():1-5. PubMed ID: 25885865 [TBL] [Abstract][Full Text] [Related]
32. Serial observation of electrocardiographic responses to corticosteroid therapy in a patient with right ventricular-predominant cardiac sarcoidosis. Toh H; Mori S; Keno M; Yokota S; Shinkura Y; Izawa Y; Nagamatsu Y; Shimoyama S; Fukuzawa K; Doi T; Hirata KI J Electrocardiol; 2018; 51(4):658-662. PubMed ID: 29997007 [TBL] [Abstract][Full Text] [Related]
33. Is there an association between clinical presentation and the location and extent of myocardial involvement of cardiac sarcoidosis as assessed by ¹⁸F- fluorodoexyglucose positron emission tomography? Mc Ardle BA; Birnie DH; Klein R; de Kemp RA; Leung E; Renaud J; DaSilva J; Wells GA; Beanlands RS; Nery PB Circ Cardiovasc Imaging; 2013 Sep; 6(5):617-26. PubMed ID: 23884290 [TBL] [Abstract][Full Text] [Related]
34. Risk stratification of patients with cardiac sarcoidosis: the ILLUMINATE-CS registry. Nabeta T; Kitai T; Naruse Y; Taniguchi T; Yoshioka K; Tanaka H; Okumura T; Sato S; Baba Y; Kida K; Tamaki Y; Matsumoto S; Matsue Y Eur Heart J; 2022 Sep; 43(36):3450-3459. PubMed ID: 35781334 [TBL] [Abstract][Full Text] [Related]
35. Usefulness of programmed ventricular stimulation in predicting future arrhythmic events in patients with cardiac sarcoidosis. Aizer A; Stern EH; Gomes JA; Teirstein AS; Eckart RE; Mehta D Am J Cardiol; 2005 Jul; 96(2):276-82. PubMed ID: 16018857 [TBL] [Abstract][Full Text] [Related]
36. Right ventricular sarcoidosis: is it time for updated diagnostic criteria? Vakil K; Minami E; Fishbein DP Tex Heart Inst J; 2014 Apr; 41(2):203-7. PubMed ID: 24808785 [TBL] [Abstract][Full Text] [Related]
37. Management and outcomes of cardiac sarcoidosis: a 20-year experience in two tertiary care centres. Fussner LA; Karlstedt E; Hodge DO; Fine NM; Kalra S; Carmona EM; Utz JP; Isaac DL; Cooper LT Eur J Heart Fail; 2018 Dec; 20(12):1713-1720. PubMed ID: 30378224 [TBL] [Abstract][Full Text] [Related]